Incyte Corporation
—- Market cap
- —
- Debt
- +$19.78B
- Cash
- −$3.38B
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: INCY stock price vs DGX: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at DGX's multiple
Needs DGX P/E.
Implied fair value · at INCY's multiple
Needs INCY P/E.
Live quote
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: INCY FY 2025 (ended Dec 31, 2025) · DGX FY 2025 (ended Dec 31, 2025).
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
INCYTE CORPORATION · implied price per share
Bear
-$7.58
Base
-$8.91
Bull
-$10.25
Quest Diagnostics Inc · implied price per share
Bear
$87.86
Base
$103.36
Bull
$118.86
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
3.83x
0.86x
Net debt / EBITDA
Leverage against operating earnings
9.31x
2.48x
Cash and equivalents
Liquid reserves on the balance sheet
$3.38B
$420.00M
Total debt
Interest-bearing obligations outstanding
$19.78B
$6.18B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
AMGEN INC
INCY vs AMGN
GILEAD SCIENCES, INC.
INCY vs GILD
VERTEX PHARMACEUTICALS INC / MA
INCY vs VRTX
REGENERON PHARMACEUTICALS, INC.
INCY vs REGN
BIOGEN INC.
INCY vs BIIB
ABBOTT LABORATORIES
INCY vs ABT
DANAHER CORP /DE/
INCY vs DHR
THERMO FISHER SCIENTIFIC INC.
INCY vs TMO
HCA Healthcare, Inc.
INCY vs HCA
LABCORP HOLDINGS INC.
INCY vs LH
WEST PHARMACEUTICAL SERVICES INC
INCY vs WST
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.